Sentinel node biopsy in breast cancer using infrared laser system first experience with PDE camera

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 3, 2011, Pages 82-86

  Polom, Karol ^a   Murawa, Dawid ^a   Michalak, Michał ^b   Murawa, Paweł ^a  

^a Wielkopolska Cancer Centre   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Breast cancer; Lymphatic flow; Sentinel node biopsy

Indexed keywords

HUMAN ALBUMIN; INDOCYANINE GREEN; NANOCOLL TC 99M; TECHNETIUM;

ADULT; AGED; ARTICLE; BREAST CANCER; CAMERA; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; FEMALE; HUMAN; INFRARED PHOTOGRAPHY; INTERMETHOD COMPARISON; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 79955044464     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.02.005     Document Type: Article

References (24)

1. Olson J.A., McCall L.M., Beitsch P., et al. Impact of immediate versus delayed axillary dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 2008, 26:3530-3535.
2. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel lymph node resection and conventional axillary lymph node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Onol 2007, 8:881-888.
3. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Eng J Med 2003, 349:546-553.
4. Giuliano A.E., Kirgan D.M., Guenther J.M., Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-398.
5. Morton D.L., Chan A.D. The concept of sentinel node localization: how it started. Semin Nucl Med 2000, 30:4-10.
6. Krag D.N., Weaver D.L., Alex J.C., Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993, 2:335-339.
7. Belacumaraswami L., Abu-Omar Y., Anastasiadis K., et al. Does off-pump total arteria grafting increase the incidence of intraoperative graft failure?. J Thorac Cardiovasc Surg 2004, 128:238-244.
8. Sekijima M., Toijmbara T., Sato S., et al. An intraoperative fluorescent imaging system in organ transplantation. Transplant Proc 2004, 36:2188-2190.
9. Parungo C.P., Ohnishi S., Kim S.W., et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 2005, 129:844-850.
10. Rasmussen J.C., Tan I.C., Marshal M.V., et al. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 2009, 20:74-82.
11. Kitai T., Inomoto T., Miwa M., Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 2005, 12(3):211-215.
12. Sevick-Muraca E.M., Sharma R., Rasmussen J.C., et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 2008, 246(3):734-741.
13. Tagaya N., Yamazaki R., Nakagawa A., et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008, 195(6):850-853.
14. Murawa D., Hirche C., Dresel S., Hunerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. Br J Surg 2009, 96(11):1289-1294.
15. Troyan S.L., Kianzad V., Gibbs-Strauss S.L., et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009, 16(10):2943-2952.
16. Hirche C., Murawa D., Mohr Z., et al. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 2010, 121(2):373-378.
17. Hojo T., Nagao T., Kikuyama M., et al. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast 2010, 19(3):210-213.
18. Ogawa M., Regino C.A., Choyke P.L., Kobayashi H. In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol Cancer Ther 2009, 8(1):232-239.
19. Olsen T.W., Lim J.I., Capone A., et al. Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol 1996, 114(1):97.
20. Alford R., Simpson H.M., Duberman J., et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 2009, 8(6):341-354.
21. Leong S.P., Donegan E., Heffernon W., et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000, 7(5):361-366.
22. Albo D., Wayne J.D., Hunt K.K., et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001, 182(4):393-398.
23. Hunting A.S., Nopp A., Johansson S.G., et al. Anaphylaxis to Patent Blue V. I. Clinical aspects. Allergy 2010, 65(1):117-123.
24. East J.M., Valentine C.S., Kanchev E., Blake G.O. Sentinel lymph node biopsy for breast cancer using blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg 2009, 9:2.